Regulatory Considerations for Addressing the Opioid Crisis

Session Description:

Join Doctors for America’s FDA Task Force for a robust discussion about addressing the opioid crisis in America. Dr. Andrew Kolodny and a special guest will be in conversation to offer historical context for what led to the current crisis, discuss current federal initiatives to address it, and outline ways the FDA can address the issue from the regulatory perspective.